New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Bone Marrow Transplantation

• Publication date

  2000-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1702347PMID 10933181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.

  1999cited by this paper
• Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation

  1998cited by this paper
• Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

  1997cited by this paper
• Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrows containing lysis-sensitive or -resistant leukemic targets.

  1996cited by this paper
• Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigens.

  1996cited by this paper
• Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrows containing lysis-sensitive or -resistant leukemic targets

  1996cited by this paper
• CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

  1995cited by this paper
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

  1995cited by this paper
• A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

  1994cited by this paper
• Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival.

  1989cited by this paper
• Engraftment of T-cell-depleted rabbit bone marrow.

  1987cited by this paper
• Allogenic bone marrow transplantation: current status and future directions.

  1983cited by this paper
• Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens.

  1983cited by this paper
• Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation.

  1981cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper
• Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

  1979cited by this paper
• Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes.

  1979cited by this paper

• Optimizing the in vitro production of immunomodulatory cells for the induction of tolerance in solid organ transplantation

  2025cites this paper
• Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts

  2014cites this paper
• Human AdV-specific T cells: persisting in vitro functionality despite lethal irradiation

  2014cites this paper
• Finding the sweet spot for donor lymphocyte infusions.

  2013cites this paper
• Irradiation of Donor Mononuclear Cells for Treatment of Chemorefractory Metastatic Solid Cancers: A Community-Based Immune Transplant Pilot Study

  2012cites this paper
• [Organ transplantation and blood transfusion].

  2011cites this paper
• Transfusion sanguine et transplantation

  2011cites this paper
• Irradiated haploidentical donor leukocyte infusions as an adoptive immunotherapy strategy to induce host-versus-tumor effects

  2011cites this paper
• This information is current as Responses In Vitro and In Vivo Enhance Chemotherapeutic Tumor T Cells Dramatically + Activated CD 4

  2009cites this paper
• Activated CD4+ T Cells Dramatically Enhance Chemotherapeutic Tumor Responses In Vitro and In Vivo

  2009cites this paper
• Experimental and clinical approaches for optimization of the graft-versus-leukemia effect

  2007cites this paper
• Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT.

  2006cites this paper
• Donor leukocyte infusions in myeloid malignancies: new strategies.

  2006cites this paper
• Graft engineering using ex vivo methods to limit GVHD: Fludarabine treatment generates superior GVL effects in allogeneic BMT

  2006cites this paper
• Long-term survival of patients with resistant lymphoma treated with tandem stem cell transplant

  2005cites this paper
• Reconstructing immunity after allogeneic transplantation

  2004cites this paper
• Hematopoietic stem cell transplant as a platform for tumor immunotherapy.

  2004cites this paper
• Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.

  2004cites this paper
• Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.

  2003cites this paper
• Donor leukocyte infusions in acute myelogenous leukemia

  2003cites this paper
• Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma.

  2003cites this paper
• Hematopoietic cell transplantation in the treatment of leukemia.

  2003cites this paper
• ‘GVHD’: graft-versus-host disease or graft-versus-Hodgkin's disease? an old acronym with new meaning

  2003cites this paper
• Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.

  2002cites this paper
• Donor lymphocyte infusion in bone marrow transplantation therapy

  2002cites this paper
• Exploiting graft-versus-tumour responses using donor leukocyte infusions.

  2001cites this paper
• Cellular therapy: donor lymphocyte infusion

  2001cites this paper
• The Graft-versus-Tumor Potential of Allogeneic Cell Therapy: An Update on Donor Leukocyte Infusions and Nonmyeloablative Allogeneic Stem Cell Transplantation

  2001cites this paper
• Blood stem cell transplantation for breast cancer: new approaches using pre- peri- post-transplant immunotherapy

  2001cites this paper